Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indianapolis TMS is a private mental health clinic in Fishers, Indiana that provides commercial, FDA-cleared transcranial magnetic stimulation services for patients with depression and related psychiatric conditions. The practice focuses on medication-resistant major depression, anxious depression, and obsessive-compulsive disorder, and also offers SPRAVATO treatment for eligible adults with persistent or treatment-resistant depression. Its core service offering is Apollo TMS/PrTMS-based, non-invasive neuromodulation delivered in an outpatient setting, with insurance-supported treatment pathways. The organization appears to operate as a specialty behavioral health provider rather than a drug-development biotech company, and it does not disclose a traditional R&D pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indianapolis TMS.